FORTE BIOSCIENCES INC's ticker is FBRX and the CUSIP is 34962G109. A total of 41 filers reported holding FORTE BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 18.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $138,009 | -31.4% | 208,383 | +7.8% | 0.00% | – |
| Q2 2023 | $201,066 | +3.0% | 193,333 | +0.1% | 0.00% | – |
| Q1 2023 | $195,121 | +101525.5% | 193,190 | +0.4% | 0.00% | – |
| Q4 2022 | $192 | -99.9% | 192,448 | +0.7% | 0.00% | – |
| Q3 2022 | $204,000 | -15.7% | 191,053 | +2.4% | 0.00% | – |
| Q2 2022 | $242,000 | -35.5% | 186,598 | -27.4% | 0.00% | – |
| Q1 2022 | $375,000 | -31.3% | 256,886 | +0.6% | 0.00% | – |
| Q4 2021 | $546,000 | +82.0% | 255,471 | +152.0% | 0.00% | – |
| Q3 2021 | $300,000 | -95.0% | 101,385 | -43.2% | 0.00% | -100.0% |
| Q2 2021 | $5,999,000 | +100.0% | 178,438 | +103.8% | 0.00% | – |
| Q1 2021 | $3,000,000 | +5.7% | 87,558 | +12.3% | 0.00% | – |
| Q4 2020 | $2,839,000 | -23.5% | 77,988 | +2.0% | 0.00% | -100.0% |
| Q3 2020 | $3,709,000 | +1210.6% | 76,473 | +293.2% | 0.00% | – |
| Q2 2020 | $283,000 | – | 19,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 84,989 | $3,094,000 | 1.41% |
| BVF INC/IL | 718,788 | $26,171,000 | 1.03% |
| ArrowMark Colorado Holdings LLC | 2,936,708 | $106,926,000 | 0.83% |
| MYDA Advisors LLC | 28,000 | $1,019,000 | 0.30% |
| Maven Securities LTD | 83,374 | $3,036,000 | 0.30% |
| Parkman Healthcare Partners LLC | 31,098 | $1,132,000 | 0.29% |
| Woodline Partners LP | 192,266 | $7,000,000 | 0.19% |
| Sepio Capital, LP | 58,591 | $2,133,000 | 0.18% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 325,000 | $11,833,000 | 0.17% |
| Perceptive Advisors | 350,000 | $12,744,000 | 0.14% |